Key result
Angiotensin-(1-7) contributes to the cardiovascular effects of ACE-inhibitors and AT1-receptor-blockers as a vasodilator and anti-trophic peptide.
Why the study?
What is the role of angiotensin-(1-7) as a vasodilator and anti-trophic peptide in cardiovascular drug therapy?
What is the role of angiotensin-(1-7) as a vasodilator and anti-trophic peptide in cardiovascular drug therapy?
Answers are grounded in this paper and cite their sources.
Angiotensin-(1-7) acts as a vasodilator and anti-trophic peptide that contributes to the cardiovascular benefits of ACE inhibitors and ARBs.
The renin-angiotensin-system (RAS) is a cascade of enzymatic reactions resulting ultimately in the formation of angiotensin II. Recent research has expanded the knowledge about the RAS by adding new components to the pathways: angiotensin-(1-5) [Ang-1-5], angiotensin-(1-7) [Ang-(1-7)], angiotensin-(1-9) [Ang-(1-9)], an ACE homologous enzyme, ACE2, and the G-protein-coupled receptor mas as a molecular receptor for Ang-(1-7). Although previous studies provided some conflicting evidence about the relevance of Ang-(1-7) in the regulation of vascular and renal function, data now demonstrate that Ang-(1-7) contributes to the cardiovascular effects of ACE-inhibitors (ACE-1) and AT1-receptor-blockers (ARBs) both in experimental conditions and in humans. This review summarizes and critically discusses the currently available experimental and clinical study evidence for the role of Ang-(1-7) as a vasodilator and anti-trophic peptide in cardiovascular drug therapy. In addition, the potential therapeutic impact of currently available RAS blocking agents (ACE-1 and ARBs) and new agents still under development (renin-inhibitors) on the RAS-effector peptides is highlighted.
No takes yet. Share an insight, caveat, or question.
Schindler et al. (2011) conducted a review in Cardiovascular disease. Angiotensin-(1-7) and RAS blocking agents was evaluated. Angiotensin-(1-7) contributes to the cardiovascular effects of ACE-inhibitors and AT1-receptor-blockers as a vasodilator and anti-trophic peptide.
Synapse has enriched 10 related papers. Consider them for comparative context: